XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	12,475	12,745	11:51
	12,445	12,690	11:36

Realtime

Geld

Brief

Zeit

12,475

12,745

11:51

12,445

12,690

11:36

XFRA CAPITAL ADJUSTMENT INFORMATION - 12.11.2024

Das Instrument 3O41 BMG611881019 LIBERTY GLOBAL LTD CL.A EQUITY wird cum Kapitalmassnahme gehandelt am 12.11.2024 und ex Kapitalmassnahme am 13.11.2024
The instrument 3O41 BMG611881019 LIBERTY GLOBAL LTD CL.A EQUITY is traded cum capital adjustment on 12.11.2024 and ex capital adjustment on 13.11.2024

Das Instrument 6CU US2362721001 DANIMER SCIENTIFIC EQUITY wird cum Kapitalmassnahme gehandelt am 12.11.2024 und ex Kapitalmassnahme am 13.11.2024
The instrument 6CU US2362721001 DANIMER SCIENTIFIC EQUITY is traded cum capital adjustment on 12.11.2024 and ex capital adjustment on 13.11.2024

Das Instrument 3O40 BMG611881274 LIBERTY GLOBAL C DL O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 12.11.2024 und ex Kapitalmassnahme am 13.11.2024
The instrument 3O40 BMG611881274 LIBERTY GLOBAL C DL O.N. EQUITY is traded cum capital adjustment on 12.11.2024 and ex capital adjustment on 13.11.2024

Das Instrument 6XP SE0009973563 XSPRAY PHARMA AB EQUITY wird ex Kapitalmassnahme gehandelt am 12.11.2024
The instrument 6XP SE0009973563 XSPRAY PHARMA AB EQUITY is traded ex capital adjustment on 12.11.2024

Das Instrument AXI FR0000051732 ATOS SE NOM. EO 1 EQUITY wird ex Kapitalmassnahme gehandelt am 12.11.2024
The instrument AXI FR0000051732 ATOS SE NOM. EO 1 EQUITY is traded ex capital adjustment on 12.11.2024

Das Instrument 8PY CA74734T1049 PYROGENESIS CANADA INC. EQUITY wird cum Kapitalmassnahme gehandelt am 12.11.2024 und ex Kapitalmassnahme am 13.11.2024
The instrument 8PY CA74734T1049 PYROGENESIS CANADA INC. EQUITY is traded cum capital adjustment on 12.11.2024 and ex capital adjustment on 13.11.2024

Das Instrument VIR ES0183746314 VIDRALA SA INH. EO 1,02 EQUITY wird ex Kapitalmassnahme gehandelt am 12.11.2024
The instrument VIR ES0183746314 VIDRALA SA INH. EO 1,02 EQUITY is traded ex capital adjustment on 12.11.2024

Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!

Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Hier klicken

Zeit	Aktuelle Nachrichten
Mi	Sichere KI mit niedriger Latenz: Atos präsentiert Sovereign AI Platform
Mi	Atos International: Eviden to Deliver Finland's Next National AI Supercomputer Tripling Its Computing Power	Paris, France - November 20, 2024 - Eviden, the Atos Groupbusiness leading in advanced computing, today announces a contract of up to 60 million euros as part of a framework agreement with CSC... ► Artikel lesen
Di	Atos International: Salon des Maires et des collectivités 2024: Software République launches the commercialization of its "U1st Vision" concept "A first in citizen-centric mobile services with a focus on health", with first deliveries scheduled for late 2	Salon des Maires et des collectivités 2024: Software République launches the commercialization of its "U1st Vision" concept"A first in citizen-centric mobile services with a focus on health", with first... ► Artikel lesen
Di	Atos International: Eviden's Supercomputers Ranked #1 and #2 for Energy Efficiency on the Green500 List	Paris, France - November 19, 2024 - Eviden, the Atos Groupbusiness leading in advanced computing, today announces that it has 55 supercomputers listed in the TOP500 ranking and 2 systems dominating... ► Artikel lesen
Mo	Atos International: Eviden enables quantum emulation in high-performance computing through dedicated software	Paris, France - November 18, 2024 - Eviden, the Atos Groupbusiness leading in advanced computing today announces the launch of Qaptiva HPC, an innovative software tailored for high-performance... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Sichere KI mit niedriger Latenz: Atos präsentiert Sovereign AI Platform

Atos International: Eviden to Deliver Finland's Next National AI Supercomputer Tripling Its Computing Power

Paris, France - November 20, 2024 - Eviden, the Atos Groupbusiness leading in advanced computing, today announces a contract of up to 60 million euros as part of a framework agreement with CSC...
► Artikel lesen

Atos International: Salon des Maires et des collectivités 2024: Software République launches the commercialization of its "U1st Vision" concept "A first in citizen-centric mobile services with a focus on health", with first deliveries scheduled for late 2

Salon des Maires et des collectivités 2024: Software République launches the commercialization of its "U1st Vision" concept"A first in citizen-centric mobile services with a focus on health", with first...
► Artikel lesen

Atos International: Eviden's Supercomputers Ranked #1 and #2 for Energy Efficiency on the Green500 List

Paris, France - November 19, 2024 - Eviden, the Atos Groupbusiness leading in advanced computing, today announces that it has 55 supercomputers listed in the TOP500 ranking and 2 systems dominating...
► Artikel lesen

Atos International: Eviden enables quantum emulation in high-performance computing through dedicated software

Paris, France - November 18, 2024 - Eviden, the Atos Groupbusiness leading in advanced computing today announces the launch of Qaptiva HPC, an innovative software tailored for high-performance...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mi	Danimer cut to underweight by Piper Sandler over financial concerns
Di	DNMR Stock Touches 52-Week Low at $6.98 Amid Market Challenges
Di	Danimer Scientific GAAP EPS of -$0.18, revenue of $8.6M beats by $0.02M
Di	Danimer Scientific Announces Third Quarter 2024 Results	BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of... ► Artikel lesen
Di	Danimer Scientific, Inc. - 10-Q, Quarterly Report

Zeit

Aktuelle Nachrichten

Danimer cut to underweight by Piper Sandler over financial concerns

DNMR Stock Touches 52-Week Low at $6.98 Amid Market Challenges

Danimer Scientific GAAP EPS of -$0.18, revenue of $8.6M beats by $0.02M

Danimer Scientific Announces Third Quarter 2024 Results

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of...
► Artikel lesen

Danimer Scientific, Inc. - 10-Q, Quarterly Report

Zeit	Aktuelle Nachrichten
02:26	Liberty Global Ltd. (LBTYA): A Bull Case Theory
Mo	Liberty Global post Sunrise spin-off gets cut to 'neutral' at UBS
Fr	Liberty Global Ltd. - 8-K, Current Report
Fr	Ofcom: EE, Virgin Media lead pay-TV complaints
13.11.	Liberty Global B stock hits 52-week low at $11.91

Zeit

Aktuelle Nachrichten

02:26

Liberty Global Ltd. (LBTYA): A Bull Case Theory

Liberty Global post Sunrise spin-off gets cut to 'neutral' at UBS

Liberty Global Ltd. - 8-K, Current Report

Ofcom: EE, Virgin Media lead pay-TV complaints

13.11.

Liberty Global B stock hits 52-week low at $11.91

Zeit	Aktuelle Nachrichten
Mi	PyroGenesis Inc.: PyroGenesis Anticipates Positive Economic Impact from Incoming Administration in the U.S.
Di	PyroGenesis Inc: PyroGenesis signs contract with steelmaker
Di	PyroGenesis Signs Contract With Major Steelmaker To Assess Use Of Plasma Torches
Di	PyroGenesis expands work with world-leading steel company
Di	PyroGenesis Inc.: PyroGenesis Signs Initial Energy Transition Contract with One of the Largest Multinational Steel Manufacturers

Zeit

Aktuelle Nachrichten

PyroGenesis Inc.: PyroGenesis Anticipates Positive Economic Impact from Incoming Administration in the U.S.

PyroGenesis Inc: PyroGenesis signs contract with steelmaker

PyroGenesis Signs Contract With Major Steelmaker To Assess Use Of Plasma Torches

PyroGenesis expands work with world-leading steel company

PyroGenesis Inc.: PyroGenesis Signs Initial Energy Transition Contract with One of the Largest Multinational Steel Manufacturers

Zeit	Aktuelle Nachrichten
12.11.	XFRA CAPITAL ADJUSTMENT INFORMATION - 12.11.2024	Das Instrument 3O41 BMG611881019 LIBERTY GLOBAL LTD CL.A EQUITY wird cum Kapitalmassnahme gehandelt am 12.11.2024 und ex Kapitalmassnahme am 13.11.2024 The instrument 3O41 BMG611881019 LIBERTY GLOBAL... ► Artikel lesen
01.11.	Vidrala-Aktie durch überraschend gute Ergebnisse gestärkt, aber Citi warnt vor "fragiler" Erholung
01.11.	Vidrala stock boosted by earnings beat, but Citi says recovery is 'fragile'
25.10.	Earnings call: Vidrala reports solid Q3 performance, maintains outlook
25.10.	VIDRALA, S.A.: VIDRALA reports a presentation including additional information about Q3 2024 results published today.

Zeit

Aktuelle Nachrichten

12.11.

XFRA CAPITAL ADJUSTMENT INFORMATION - 12.11.2024

01.11.

Vidrala-Aktie durch überraschend gute Ergebnisse gestärkt, aber Citi warnt vor "fragiler" Erholung

01.11.

Vidrala stock boosted by earnings beat, but Citi says recovery is 'fragile'

25.10.

Earnings call: Vidrala reports solid Q3 performance, maintains outlook

25.10.

VIDRALA, S.A.: VIDRALA reports a presentation including additional information about Q3 2024 results published today.

Zeit	Aktuelle Nachrichten
14.11.	Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Xspray Pharma AB	With effect from November 15, 2024, the subscription rights of Xspray Pharma AB will be traded on the list for Equity rights. Trading will continue up until and including November 26, 2024. Instrument:... ► Artikel lesen
12.11.	XFRA CAPITAL ADJUSTMENT INFORMATION - 12.11.2024	Das Instrument 3O41 BMG611881019 LIBERTY GLOBAL LTD CL.A EQUITY wird cum Kapitalmassnahme gehandelt am 12.11.2024 und ex Kapitalmassnahme am 13.11.2024 The instrument 3O41 BMG611881019 LIBERTY GLOBAL... ► Artikel lesen
06.11.	XSpray Pharma AB: Interim Report Third Quarter 2024	July - September 2024, GroupNet sales amounted to SEK 0 thousand (0)Loss before tax amounted to SEK -82,272 thousand (-38,942)Earnings per share before dilution amounted to SEK -2.44 (-1.59)Cash flow... ► Artikel lesen
06.11.	XSpray Pharma AB: Xspray resolves on a rights issue of approximately SEK 135 million and raises a loan of SEK 100 million	THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH... ► Artikel lesen
19.09.	Xspray Pharma AB: Xspray Pharma Announces Positive FDA Meeting and Plans for Dasynoc NDA Resubmission	Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY), a pharmaceutical company leveraging its proprietary HyNap technology to develop enhanced cancer therapies, today announced significant progress... ► Artikel lesen

Zeit

Aktuelle Nachrichten

14.11.

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Xspray Pharma AB

With effect from November 15, 2024, the subscription rights of Xspray Pharma AB will be traded on the list for Equity rights. Trading will continue up until and including November 26, 2024. Instrument:...
► Artikel lesen

12.11.

XFRA CAPITAL ADJUSTMENT INFORMATION - 12.11.2024

06.11.

XSpray Pharma AB: Interim Report Third Quarter 2024

July - September 2024, GroupNet sales amounted to SEK 0 thousand (0)Loss before tax amounted to SEK -82,272 thousand (-38,942)Earnings per share before dilution amounted to SEK -2.44 (-1.59)Cash flow...
► Artikel lesen

06.11.

XSpray Pharma AB: Xspray resolves on a rights issue of approximately SEK 135 million and raises a loan of SEK 100 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH...
► Artikel lesen

19.09.

Xspray Pharma AB: Xspray Pharma Announces Positive FDA Meeting and Plans for Dasynoc NDA Resubmission

Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY), a pharmaceutical company leveraging its proprietary HyNap technology to develop enhanced cancer therapies, today announced significant progress...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
ATOS SE	0,175	-9,23 %
DANIMER SCIENTIFIC INC	5,850	0,00 %
LIBERTY GLOBAL LTD CL A	12,200	-3,10 %
PYROGENESIS INC	0,441	-5,27 %
VIDRALA SA	94,90	-0,84 %
XSPRAY PHARMA AB	3,565	0,00 %

Unternehmen / Aktien

Kurs

ATOS SE

0,175

-9,23 %

DANIMER SCIENTIFIC INC

5,850

0,00 %

LIBERTY GLOBAL LTD CL A

12,200

-3,10 %

PYROGENESIS INC